Navigation Links
Genus Oncology, LLC Announces Orphan Drug Status for GO-203-2c for Treatment of Pancreatic Cancer
Date:3/8/2011

rom a series of first-in-class agents synthesized to target MUC1, an oncoprotein that is overexpressed in many diverse human carcinomas including breast, prostate, lung, colon, pancreatic, and ovarian that have been associated with poor prognosis. Of an estimated 1.4 million cancer cases diagnosed each year in the US, about 900,000 overexpress MUC1, thus making it an attractive target for developing anti-cancer drugs. To date, there are no approved agents that target MUC1.

About Genus Oncology, LLC

Genus Oncology, LLC, is a clinical-stage company formed in 2007 with a mission of discovering, developing, and commercializing new anti-cancer agents that target the MUC1 oncoprotein. Genus' intellectual capital includes more than 20 years of research at Dana-Farber Cancer Institute (DFCI) and Harvard Medical School, and a senior management team with significant pharmaceutical industry experience leading successful discovery, development, and commercialization initiatives. For more information, please visit www.genusoncology.com.


'/>"/>
SOURCE Genus Oncology, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Genus Oncology, LLC Announces Initiation of Phase I Trial of GO-203-2c in Patients With Solid Tumors
2. US Oncology, Inc. to Exhibit iKnowMed(TM) at the 2009 ASCO EHR Symposium: Harnessing the EHR: From Incentives to Sustainability
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , Sept. 3,  2015 About ... bio-artificial devices, which are implanted or integrated ... organs. These include artificial heart, kidney, pancreas, ... polymers (polyurethane, polysulfone, and porous polypropylene), biologics, ... artificial organs. These organs are incorporated with ...
(Date:9/3/2015)... 3, 2015 About dry eye syndrome Dry ... to deficient tear production or quick tear evaporation or ... types: aqueous tear deficient dry eye and evaporative dry ... do not produce enough tears, whereas meibomian gland dysfunction ... to slow tear evaporation and maintain tear stability. The ...
(Date:9/3/2015)... Sept. 3, 2015  Ascendis Pharma A/S ... biotechnology company that applies its innovative TransCon ... today announced plans to present at several ... Healthcare Conference in BostonDate: , Thursday, September ... of America Merrill Lynch Global Healthcare Conference ...
Breaking Medicine Technology:Global Artificial Organ Market 2015-2019 2Global Dry Eye Syndrome Market 2015-2019 2Ascendis Pharma A/S to Present at Three Upcoming Investor Conferences 2
... WIRE)--May 21, 2007 - Cougar Biotechnology,Inc. (OTCBB:CGRB) today ... on the Company's prostate cancer drug candidate CB7630,(abiraterone ... Annual Meeting, which is currently taking place,in Anaheim, ... A.,Yap from the Cancer Research UK Centre for ...
... 40/12.5 and 40/25 mg/day and Amlodipine +,Benazepril ... Society of,Hypertension Twenty-Second Annual Scientific Meeting, PARSIPPANY, ... data,presented today at the American Society of ... Chicago,demonstrated that the fixed-dose combination Benicar HCT,(olmesartan ...
Cached Medicine Technology:Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 2Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 3Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 4Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 2Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 3Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 4Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 5Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 6Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 7Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 8
(Date:9/4/2015)... ... ... According to an article published August 18th on Neurology Advisor, ... force that is great enough to cause a traumatic brain injury. This new polymer, ... coaches or officials would instantly see if a player may have suffered a head ...
(Date:9/4/2015)... ... 2015 , ... Mile High Connects today releases “First and Last Mile Connections,” ... sidewalks, bike paths, and other vital supports severely limit access to public transportation for ... dollars to expand public transit, there’s very little support for safe and convenient access ...
(Date:9/4/2015)... ... September 04, 2015 , ... Georgia Insurance Advisors, a locally ... effort to provide for the family of Grace, a young local girl battling ... often leads to diastolic dysfunction – the inability to adequately move blood through ...
(Date:9/4/2015)... ... 2015 , ... Scalability Experts (SE) announced that it has ... year’s Microsoft Worldwide Partner Conference that was held in Orlando, Florida. This ... Data Platform services, the 2015 HP and Microsoft “Outstanding Frontline Partner” for ...
(Date:9/4/2015)... ... ... Mike Day, a former Navy SEAL who was shot 27 times during a ... on October 10th. , Mike is running the race to raise awareness and funding ... treatments that restore their quality of life. More than 300,000 post 9/11 ...
Breaking Medicine News(10 mins):Health News:New Article on Head Injury Detection Technology Highlights Implications for Head Injury Detection in Sports, says The Law Offices of Burg & Brock 2Health News:Missed Connections in Metro Denver Transit 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2
... By Kathleen Doheny HealthDay Reporter , THURSDAY, ... oil supplements may reduce their breast cancer risk, a new ... benefits of 15 different so-called "specialty" supplements to see if ... White, an epidemiologist at the Fred Hutchinson Cancer Research Center ...
... ... a series of log home raisings across the country, on Saturday July 24th, showcasing our custom ... ... Across America, a series of log home raisings across the country, on Saturday July 24th, showcasing ...
... million older adults will reside in the United States, ... Administration on Aging. Potential issues are compounded by the ... elder care. As part of the solution, an interdisciplinary ... health record (EHR) technology to more efficiently meet increasing ...
... ... June , ... (PRWEB) -- Suite101.com, a global content site that provides trusted and reliable information to ... 2010, providing a window into consumer online reading behavior. In June, the most popular articles ...
... Surgery can improve patient outcomes in individuals with severe ... being seen in,hospitals across the country. Patients who undergo ... than those who undergo traditional surgery. The paper will ... Orthopaedic Foot and Ankle Society (AOFAS, abstract 348) in ...
... ... availability of the EV30T, a new addition to its powerful line of ... the United States. The U.S. Department of Health and Human Services reports ... care spending, decreased productivity and increased safety risks. Lifeloc is proud to ...
Cached Medicine News:Health News:Fish Oil Supplements Linked to Lower Risk of Breast Cancer: Study 2Health News:Fish Oil Supplements Linked to Lower Risk of Breast Cancer: Study 3Health News:Logs Across America Event from Southland Log Homes 2Health News:Electronic health records prime clinicians to provide progressive care to older adults 2Health News:Suite 101.com Provides Insight Into Consumer Reading Behavior Online 2Health News:Suite 101.com Provides Insight Into Consumer Reading Behavior Online 3Health News:Suite 101.com Provides Insight Into Consumer Reading Behavior Online 4Health News:New surgery improves outcomes for severe flat foot deformity 2Health News:New surgery improves outcomes for severe flat foot deformity 3Health News:Lifeloc supports workplace breath alcohol testing and announces new robust solution, the EV30T 2Health News:Lifeloc supports workplace breath alcohol testing and announces new robust solution, the EV30T 3